Filing Details

Accession Number:
0001140361-15-023276
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-04 18:32:28
Reporting Period:
2015-06-02
Filing Date:
2015-06-04
Accepted Time:
2015-06-04 18:32:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1059790 Pozen Inc POZN Pharmaceutical Preparations (2834) 621657552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425357 Marie Gilda Thomas C/O Pozen Inc.
1414 Raleigh Road, Suite 400
Chapel Hill NC 27517
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-02 2,830 $5.33 56,605 No 4 M Direct
Common Stock Disposition 2015-06-02 2,830 $7.51 53,775 No 4 S Direct
Common Stock Acquisiton 2015-06-02 4,125 $5.33 57,900 No 4 M Direct
Common Stock Disposition 2015-06-02 4,125 $7.51 53,775 No 4 S Direct
Common Stock Acquisiton 2015-06-03 16,600 $5.33 70,375 No 4 M Direct
Common Stock Disposition 2015-06-03 16,600 $7.53 53,775 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-06-02 2,830 $0.00 2,830 $5.33
Common Stock Stock Option Disposition 2015-06-02 4,125 $0.00 4,125 $5.33
Common Stock Stock Option Disposition 2015-06-03 16,600 $0.00 16,600 $5.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,765 2020-03-15 No 4 M Direct
16,640 2020-03-15 No 4 M Direct
40 2020-03-15 No 4 M Direct
Footnotes
  1. Option exercises and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $7.51 to 7.53.
  3. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  4. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $7.52 to 7.56.
  5. The options vested in four equal annual installments, with the initial vesting date occurring on March 15, 2011.